Literature DB >> 23219234

MIRU-VNTR profiles of three major Mycobacterium tuberculosis spoligotypes found in western India.

Anirvan Chatterjee1, Nerges Mistry.   

Abstract

We performed 12 loci MIRU-VNTR on 327 Mycobacterium tuberculosis (Mtb) isolates belonging to three major spoligotypes MANU1, CAS1_Delhi and Beijing from Mumbai, western India and two proximal rural locations. Complete allele and drug susceptibility data was available for 232 isolates. These included 143 MANU1 (ST100), 65 CAS1_Delhi (ST26) and 24 Beijing (ST1) isolates. Of the 232 isolates, 26 were rural consisting 6 CAS1_Delhi and 20 MANU1 isolates. Using eBURST multi-locus sequence typing (MLST), cluster analyses was performed for each of the spoligotypes and drug susceptibility profiles. MANU1 MLST consisted of 90 related isolates (clustered and grouped) and 53 singletons; CAS1_Delhi MLST consisted of 44 related isolates and 21 singletons; Beijing MLST consisted of 10 related isolates and 14 singletons. Although the number of related isolates were different in MANU1 (63%), CAS1_Delhi (68%) and Beijing (42%) clusters, it was not statistically significant. Furthermore, it was observed that while MANU1 and CAS1_Delhi singletons (n = 74) had only 12 (16%) MDR isolates, the Beijing MLST had 8/14 (57%) MDR singleton isolates. Phylogenetic ananlysis using minimum spanning tree (MST) and a UPGMA radial tree revealed MANU1 had the largest number of nodes as compared to the CAS1_Delhi and Beijing spoligotypes. Additionally the CAS isolates were more homogeneous than the MANU1 isolates. The 12 loci MIRU-VNTR was used to provide greater discrimination than spoligotyping, but 6 of the 12 loci provided less than 50% discriminatory power. The highest discrimination was achieved using locus 26 (80%). Our results concur with recent reports that the most discriminatory MIRU-VNTR combination varied across different lineages. The results also highlight the need for more robust genetic markers for studying the transmission of Mtb in endemic regions like India.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23219234     DOI: 10.1016/j.tube.2012.10.004

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  9 in total

1.  Spoligotype and Drug Susceptibility Profiles of Mycobacterium tuberculosis Complex Isolates in Golestan Province, North Iran.

Authors:  Noormohamad Mansoori; Farzam Vaziri; Sirus Amini; Sharareh Khanipour; Shahin Pourazar Dizaji; Masoumeh Douraghi
Journal:  Infect Drug Resist       Date:  2020-07-01       Impact factor: 4.003

2.  Introducing the Best Six Loci in Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat (MIRU-VNTR) Typing for Mycobacterium Tuberculosis Genotyping.

Authors:  Mahdis Ghavidel; Keyvan Tadayon; Nader Mosavari; Kimiya Nourian; Hamid Reza BahramiTaghanaki; Gholam Reza Mohammadi; Mohammad Rashtibaf; Kiarash Ghazvini
Journal:  Rep Biochem Mol Biol       Date:  2019-10

3.  Tuberculous Lymphadenitis in Ethiopia Predominantly Caused by Strains Belonging to the Delhi/CAS Lineage and Newly Identified Ethiopian Clades of the Mycobacterium tuberculosis Complex.

Authors:  Fantahun Biadglegne; Matthias Merker; Ulrich Sack; Arne C Rodloff; Stefan Niemann
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

4.  Genotyping of clinical Mycobacterium tuberculosis isolates based on IS6110 and MIRU-VNTR polymorphisms.

Authors:  Anna Żaczek; Anna Brzostek; Arkadiusz Wojtasik; Jarosław Dziadek; Anna Sajduda
Journal:  Biomed Res Int       Date:  2013-12-17       Impact factor: 3.411

5.  Evaluation of the impact of polyclonal infection and heteroresistance on treatment of tuberculosis patients.

Authors:  Mansour Kargarpour Kamakoli; Hamid Reza Sadegh; Ghazaleh Farmanfarmaei; Morteza Masoumi; Abolfazl Fateh; Gholamreza Javadi; Fatemeh Rahimi Jamnani; Farzam Vaziri; Seyed Davar Siadat
Journal:  Sci Rep       Date:  2017-01-25       Impact factor: 4.379

6.  Genetic diversity & drug sensitivity profiles of Mycobacterium tuberculosis isolates from two slums of Jaipur city, Rajasthan, India.

Authors:  Bharti Malhotra; Deepti Dashora; Vipin Kumar; Sumit Goyal; Bhavana Sharma; Madhu Kumar; Kailash Narayan Gupta; Vishnu Dutt Sharma; D S Chauhan; Kiran Katoch; Vishwa Mohan Katoch
Journal:  Indian J Med Res       Date:  2017-01       Impact factor: 2.375

7.  Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trial.

Authors:  Adam A Witney; Anna L E Bateson; Amina Jindani; Patrick P J Phillips; David Coleman; Neil G Stoker; Philip D Butcher; Timothy D McHugh
Journal:  BMC Med       Date:  2017-03-29       Impact factor: 8.775

8.  Genetic Diversity of Mycobacterium tuberculosis Isolates from Assam, India: Dominance of Beijing Family and Discovery of Two New Clades Related to CAS1_Delhi and EAI Family Based on Spoligotyping and MIRU-VNTR Typing.

Authors:  Kangjam Rekha Devi; Rinchenla Bhutia; Shovonlal Bhowmick; Kaustab Mukherjee; Jagadish Mahanta; Kanwar Narain
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

9.  Local adaptive evolution of two distinct clades of Beijing and T families of Mycobacterium tuberculosis in Chongqing: a Bayesian population structure and phylogenetic study.

Authors:  Peng-Kuan Liang; Chao Zheng; Xiao-Fang Xu; Zhe-Ze Zhao; Chang-Song Zhao; Chang-He Li; David Couvin; Yann Reynaud; Thierry Zozio; Nalin Rastogi; Qun Sun
Journal:  Infect Dis Poverty       Date:  2020-06-01       Impact factor: 4.520

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.